DLB
Dolby Laboratories, Inc. Financials Patent Owners & Lessors Russell 3000
$61.99Close
$48.23 – $68.2652-week range
Nov 17, 2026Next report · after the close
Highlights
Cautions
- Not in an uptrend 4 of 8 trend conditions
- Lagging the market RS 49 · weaker than 51% of stocks over 12 months
- Earnings shrinking EPS −36% year on year
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
9%
1wk
down 1.4%
price change
1mo
up 5.5%
price change
12-month return
down 3%
market up 11% ·
its own down 13%
F-score
—
— Not assessed
Altman Z″
9.77
Low risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
—
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
up 6%
year on year
EPS growth
down 36%
latest quarter · -42 pts
Sales growth
down 3%
latest quarter · -10 pts
ROE
up 10%
return on equity
Free cash margin
—
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
Repair signals
- Revenue reaccelerating (-2% then +6%)
Trade setup
ATR%
2.5%
$1.56 a day · 2×ATR $58.87
RS
49 / 99
vs the universe
Trend
4 / 8
trend template
Relative volume
0.8×
vs 50-day average
Up/down volume
1.06
50 sessions
Implied move
—
no option chain · report Nov 17, 2026
Trend template · 4 of 8
- Price above the 150 and 200-day averages: passes
- 150-day average above the 200-day: fails
- 200-day average rising for a month: fails
- 50-day average above the 150 and 200-day: passes
- Price above the 50-day average: passes
- At least 30% above the 52-week low: fails
- Within 25% of the 52-week high: passes
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- No material dilution
- Margins and revenue not shrinking
Last reported
Jul 30, 2026
Financials
- Gross 88%
- Net 19%
- Cash
- Long-term debt
| FY2020Sep 25, 2020 | FY2021Sep 24, 2021 | FY2022Sep 30, 2022 | FY2023Sep 29, 2023 | FY2024Sep 27, 2024 | FY2025Sep 26, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B |
| Gross margin | 87% | 90% | 89% | 88% | 89% | 88% |
| Operating income | $218.7M | $344.4M | $206.6M | $215.8M | $258.3M | $265.0M |
| Net income | $231.4M | $310.2M | $184.1M | $200.7M | $261.8M | $255.0M |
| Net margin | 20% | 24% | 15% | 15% | 21% | 19% |
| Earnings per share | $2.25 | $2.97 | $1.81 | $2.05 | $2.69 | $2.62 |
| Cash | $1.1B | $1.2B | $620.1M | $745.4M | $482.0M | $701.9M |
| Shareholders' equity | $2.4B | $2.6B | $2.2B | $2.4B | $2.5B | $2.6B |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Jul 30, 2026 | Quarterly ↗ | Jun 26, 2026 | 34d |
| Apr 30, 2026 | Quarterly ↗ | Mar 27, 2026 | 34d |
| Jan 29, 2026 | Quarterly ↗ | Dec 26, 2025 | 34d |
| Nov 18, 2025 | Annual ↗ | Sep 26, 2025 | 53d |
| Jul 31, 2025 | Quarterly ↗ | Jun 27, 2025 | 34d |
| May 1, 2025 | Quarterly ↗ | Mar 28, 2025 | 34d |
| Jan 30, 2025 | Quarterly ↗ | Dec 27, 2024 | 34d |
| Nov 19, 2024 | Annual ↗ | Sep 27, 2024 | 53d |
| Aug 7, 2024 | Quarterly ↗ | Jun 28, 2024 | 40d |
| May 2, 2024 | Quarterly ↗ | Mar 29, 2024 | 34d |
| Feb 2, 2024 | Quarterly ↗ | Dec 29, 2023 | 35d |
| Nov 17, 2023 | Annual ↗ | Sep 29, 2023 | 49d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 27, 2026 | Director or officer change · Regulation FD · Other events ↗ |
| Jul 30, 2026 | Results · Other events ↗ |
| Apr 30, 2026 | Results · Other events ↗ |
| Feb 6, 2026 | Shareholder vote ↗ |
| Jan 29, 2026 | Results · Other events ↗ |
| Nov 18, 2025 | Results · Other events ↗ |
| Nov 14, 2025 | Director or officer change ↗ |
| Jul 31, 2025 | Results · Other events ↗ |
| May 1, 2025 | Results · Other events ↗ |
| Feb 7, 2025 | Charter or bylaws · Shareholder vote ↗ |
| Jan 29, 2025 | Results · Other events ↗ |
| Nov 19, 2024 | Material agreement · Results · New obligation · Other events ↗ |